Giakoustidis Dimitrios, Giakoustidis Alexander, Goulopoulos Thomas, Arabatzi Ntina, Kainantidis Aristidis, Zaraboukas Thomas
Department of Surgery, European Interbalkan Medical Centre, Thessaloniki, Greece.
Division of Transplant Surgery, Department of Surgery, Medical School, Aristotle University of Thessaloniki, Greece.
Ann Hepatobiliary Pancreat Surg. 2017 Nov;21(4):228-231. doi: 10.14701/ahbps.2017.21.4.228. Epub 2017 Nov 30.
Primary hepatic leiomyosarcoma (PHL) is an extremely rare tumor. The tumor has no specific presentations and often diagnosis is delayed until it reaches a significant size. We report the case of a 69-year-old female presented with a huge PHL. Due to size of the tumor and to be operable, the patient subjected to right portal vein embolization (PVE) and selective embolization of segment V. Four weeks after the PVE, liver resection was conducted (Segments V+VI bisegmentectomy plus resection of IVA). The patient had an uncomplicated post-operative course, and discharged at the 8th post-operative day. Diagnosis of PHL was confirmed by histopathological and immunohistochemical examinations. The patient refused to receive adjuvant chemotherapy, and revealed evidence of recurrence six months after the operation, and finally died 12 months after the operation and 16 months after initial diagnosis. PHL is an extremely rare tumor and often in first presentation has significant size. Radical surgery with adjuvant chemotherapy is key feature for prolonged survival.
原发性肝平滑肌肉瘤(PHL)是一种极为罕见的肿瘤。该肿瘤没有特异性表现,诊断往往会延迟,直到肿瘤长得很大。我们报告一例69岁女性患有巨大PHL的病例。由于肿瘤大小及可切除性,患者接受了右门静脉栓塞术(PVE)及Ⅴ段选择性栓塞。PVE四周后,进行了肝切除术(Ⅴ+Ⅵ段双段切除术加ⅣA段切除)。患者术后恢复顺利,术后第8天出院。通过组织病理学和免疫组化检查确诊为PHL。患者拒绝接受辅助化疗,术后6个月出现复发迹象,最终于术后12个月、初次诊断后16个月死亡。PHL是一种极为罕见的肿瘤,初次就诊时往往体积较大。根治性手术联合辅助化疗是延长生存期的关键。